In re Meredith Corporation Securities Litigation
|Court:||United States District Court, Southern District of Iowa, Central Division|
|Judge:||Hon. Charles R. Wolle|
|Class Period:||01/31/2018 - 09/30/2019|
|Case Contacts:||John C. Browne, Adam H. Wierzbowski, James M. Fee, R. Ryan Dykhouse, Alexander T. Payne|
This is a securities class action on behalf of all purchasers of the securities of Meredith Corporation (“Meredith” or “the Company”) between January 31, 2018 and September 30, 2019, inclusive (the “Class Period”).
Defendant Meredith, headquartered in Des Moines, Iowa, is an American media conglomerate that owns magazines, television stations, and websites, reaching over 175 million unduplicated American consumers. Meredith’s publications have a readership of more than 120 million, paid circulation of more than 40 million, nearly 135 million monthly unique website visitors, and broadcast television stations which reach 11 percent of United States households
The action seeks to pursue remedies against Meredith and several of its most senior executives for violations of the federal securities laws. Plaintiff alleges that during the Class Period, Defendants issued materially false and misleading statements regarding the Company’s acquisition of Time, Inc. (“Time”). Specifically, Defendants failed to disclose: (i) that the Company’s financial reporting was deficient in its controls for establishing the fair value of the assets and liabilities that Meredith had acquired from Time; (ii) that integrating Time’s assets and elevating advertising revenue from the print and digital performance of Time’s assets would occur over a series of years and require additional investment spending; and (iii) that the substantial number of low margin magazine subscriptions inside the legacy Time brands would require additional investment spending. Defendants failure to disclose these defects caused harm to Plaintiff and the Class.
On November 25, 2019, the Hon. Charles R. Wolle appointed the City of Plantation Police Officers’ Pension Fund as the Lead Plaintiff, and Bernstein Litowitz Berger and Grossmann LLP as Lead Counsel, for the Class.
Plaintiff filed its Amended Complaint on March 9, 2020. On October 28, 2020, the Court dismissed the Complaint. On November 23, 2020, Plaintiff appealed this dismissal to the Eighth Circuit Court of Appeals, and Plaintiff filed its opening appeal brief with the Eighth Circuit on January 21, 2021.
Other Cases of Interest
District of New Jersey Salvatore J. Graziano, Adam H. Wierzbowski, Adam Hollander, Robert Kravetz, Jim Briggs
Venator Materials PLC
Southern District of Texas, Houston Division John C. Browne, Michael D. Blatchley, Nicholas Gersh
Allergan, Inc. (Drug Pricing)
District of New Jersey John C. Browne, Lauren McMillen Ormsbee, Michael Mathai, Nicholas Gersh, Erika Connolly
Myriad Genetics, Inc.
District of Utah Hannah Ross, Adam H. Wierzbowski, Abe Alexander, Matthew Traylor, Nicholas Gersh
Western District of Pennsylvania Salvatore J. Graziano, Hannah Ross, Adam H. Wierzbowski, Jai K. Chandrasekhar, Alexander T. Payne, Jared Hoffman, Emily Strickland, Thomas Sperber, Jesse L. Jensen
Southern District of New York John C. Browne, David Wales, John Rizio-Hamilton, Jeremy P. Robinson, Laura Lefkowitz, Catherine E. van Kampen
Merck & Co., Inc. (Vioxx-Related)
District of New Jersey Salvatore J. Graziano, Katherine M. Sinderson, David Wales, Adam H. Wierzbowski, Abe Alexander, Catherine E. van Kampen
Perrigo Company plc
District of New Jersey James A. Harrod, Jesse L. Jensen, R. Ryan Dykhouse, Reiko Cyr, Catherine E. van Kampen
Southern District of New York John C. Browne, Jai K. Chandrasekhar, Jesse L. Jensen, Kate Aufses, Alex Dickin, Catherine E. van Kampen
GT Advanced Technologies Inc.
District of New Hampshire John C. Browne, Lauren McMillen Ormsbee, Catherine E. van Kampen